Expression of Programmed Cell Death Ligand in Cutaneous Squamous Cell Carcinoma and Treatment of Locally Advanced Disease With Pembrolizumab

导出原文传递

翻译打印收藏纠错

作者： Stevenson, Mary L. ^[1] ; Wang, Claire Q. F. ^[2] ; Abikhair, Melody ^[3] ; Roudiani, Nazanin ^[4] ; Felsen, Diane ; Krueger, James G. ; Pavlick, Anna C. ; Carucci, John A.

作者单位： NYU, Langone Med Ctr, Laura & Isaac Perlmutter Canc Ctr, New York, NY USA ^[1] NYU, Langone Med Ctr, Ronald O Perelman Dept Dermatol, 240 E 38th St, New York, NY 10016 USA ^[2] Rockefeller Univ, Lab Investigat Dermatol, 1230 York Ave, New York, NY 10021 USA ^[3] Cornell Univ, Inst Pediat Urol, Weill Cornell Med, New York, NY 10021 USA ^[4]

发布时间 2017-12-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

JAMA dermatology

2017年153卷4期

299-303页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Expression of Programmed Cell Death Ligand in Cutaneous Squamous Cell Carcinoma and Treatment of Locally Advanced Disease With Pembrolizumab

JAMA dermatology

相似文献

JAMA dermatology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Expression of Programmed Cell Death Ligand in Cutaneous Squamous Cell Carcinoma and Treatment of Locally Advanced Disease With Pembrolizumab

JAMA dermatology

相似文献

JAMA dermatology

相关期刊

检索历史清除